These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1683640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lysyl oxidase and collagenase in experimental acute and chronic liver injury.
    Carter EA, McCarron MJ, Alpert E, Isselbacher KJ.
    Gastroenterology; 1982 Mar; 82(3):526-34. PubMed ID: 6119272
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Prolyl hydroxylase activity in liver specimens in chronic liver diseases (author's transl)].
    Langness U, Clausnitzer H, Verspohl M, Grasedyck K.
    Med Klin; 1978 Aug 25; 73(34):1179-82. PubMed ID: 210365
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Serum cathepsin activity in chronic liver diseases].
    Kucharz EJ, Kucharz M.
    Z Gesamte Inn Med; 1986 Nov 15; 41(22):636-8. PubMed ID: 3031888
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
    Schneider M, Voss B, Högemann B, Eberhardt G, Gerlach U.
    Hepatogastroenterology; 1989 Dec 15; 36(6):506-10. PubMed ID: 2693303
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum lysyl oxidase activity in patients with various liver diseases.
    Sakamoto M, Murawaki Y, Hirayama C.
    Gastroenterol Jpn; 1987 Dec 15; 22(6):730-6. PubMed ID: 2895030
    [Abstract] [Full Text] [Related]

  • 18. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics.
    Ventura P, Rosa MC, Abbati G, Marchini S, Grandone E, Vergura P, Tremosini S, Zeneroli ML.
    Liver Int; 2005 Feb 15; 25(1):49-56. PubMed ID: 15698398
    [Abstract] [Full Text] [Related]

  • 19. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun 15; 9(3):148-50. PubMed ID: 11412388
    [Abstract] [Full Text] [Related]

  • 20. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
    Soresi M, Bascone F, Agate V, Carroccio A, Barresi E, Cartabellotta A, Aragona F, Montalto G.
    Recenti Prog Med; 1997 Feb 15; 88(2):73-6. PubMed ID: 9148370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.